Cargando…

Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy

While the antiarrhythmic drug amiodarone is commonly used in clinical practice, it has a narrow therapeutic index that can lead to acute overdose. One proposed method to deal with this toxicity is lipid emulsion therapy, which may potentially quench the free amiodarone in blood and prevent its furth...

Descripción completa

Detalles Bibliográficos
Autores principales: Avedissian, Sean N., Pham, Michelle, Joshi, Medha D., Scheetz, Marc H., Salamatipour, Ashkan, Panickar, Jeffin M., Hlukhenka, Khrystyna, Miglis, Cristina, Chalkias, Athanasios, Xanthos, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069539/
https://www.ncbi.nlm.nih.gov/pubmed/33924314
http://dx.doi.org/10.3390/pharmaceutics13040539
_version_ 1783683260977512448
author Avedissian, Sean N.
Pham, Michelle
Joshi, Medha D.
Scheetz, Marc H.
Salamatipour, Ashkan
Panickar, Jeffin M.
Hlukhenka, Khrystyna
Miglis, Cristina
Chalkias, Athanasios
Xanthos, Theodoros
author_facet Avedissian, Sean N.
Pham, Michelle
Joshi, Medha D.
Scheetz, Marc H.
Salamatipour, Ashkan
Panickar, Jeffin M.
Hlukhenka, Khrystyna
Miglis, Cristina
Chalkias, Athanasios
Xanthos, Theodoros
author_sort Avedissian, Sean N.
collection PubMed
description While the antiarrhythmic drug amiodarone is commonly used in clinical practice, it has a narrow therapeutic index that can lead to acute overdose. One proposed method to deal with this toxicity is lipid emulsion therapy, which may potentially quench the free amiodarone in blood and prevent its further distribution to target organs and tissues. In this study, we utilize an established swine model to examine the effects of Intralipid™ (IL) administration for acute amiodarone toxicity. A total of 14 pigs received an overdose of intravenous amiodarone. After twenty minutes, half of the pigs (n = 7) received IL while the control group (n = 7) received normal saline. Serum concentrations of amiodarone were then analyzed using a validated high-performance liquid chromatography (HPLC) method. Noncompartmental pharmacokinetic analyses were performed on the observed concentrations. There were no statistical differences in the area under the concentration time curve (6 h) or clearance, but there was a difference in the half-life between the two groups (3.12 vs. 0.85 h, p = 0.01). The administration of IL did not statistically change the overall exposure of amiodarone in the blood in the first 6 h; however, trends toward prolonged blood retention in the IL group were seen.
format Online
Article
Text
id pubmed-8069539
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80695392021-04-26 Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy Avedissian, Sean N. Pham, Michelle Joshi, Medha D. Scheetz, Marc H. Salamatipour, Ashkan Panickar, Jeffin M. Hlukhenka, Khrystyna Miglis, Cristina Chalkias, Athanasios Xanthos, Theodoros Pharmaceutics Article While the antiarrhythmic drug amiodarone is commonly used in clinical practice, it has a narrow therapeutic index that can lead to acute overdose. One proposed method to deal with this toxicity is lipid emulsion therapy, which may potentially quench the free amiodarone in blood and prevent its further distribution to target organs and tissues. In this study, we utilize an established swine model to examine the effects of Intralipid™ (IL) administration for acute amiodarone toxicity. A total of 14 pigs received an overdose of intravenous amiodarone. After twenty minutes, half of the pigs (n = 7) received IL while the control group (n = 7) received normal saline. Serum concentrations of amiodarone were then analyzed using a validated high-performance liquid chromatography (HPLC) method. Noncompartmental pharmacokinetic analyses were performed on the observed concentrations. There were no statistical differences in the area under the concentration time curve (6 h) or clearance, but there was a difference in the half-life between the two groups (3.12 vs. 0.85 h, p = 0.01). The administration of IL did not statistically change the overall exposure of amiodarone in the blood in the first 6 h; however, trends toward prolonged blood retention in the IL group were seen. MDPI 2021-04-13 /pmc/articles/PMC8069539/ /pubmed/33924314 http://dx.doi.org/10.3390/pharmaceutics13040539 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Avedissian, Sean N.
Pham, Michelle
Joshi, Medha D.
Scheetz, Marc H.
Salamatipour, Ashkan
Panickar, Jeffin M.
Hlukhenka, Khrystyna
Miglis, Cristina
Chalkias, Athanasios
Xanthos, Theodoros
Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy
title Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy
title_full Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy
title_fullStr Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy
title_full_unstemmed Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy
title_short Pharmacokinetic Disposition of Amiodarone When Given with an Intralipid Rescue Strategy
title_sort pharmacokinetic disposition of amiodarone when given with an intralipid rescue strategy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069539/
https://www.ncbi.nlm.nih.gov/pubmed/33924314
http://dx.doi.org/10.3390/pharmaceutics13040539
work_keys_str_mv AT avedissianseann pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT phammichelle pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT joshimedhad pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT scheetzmarch pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT salamatipourashkan pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT panickarjeffinm pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT hlukhenkakhrystyna pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT migliscristina pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT chalkiasathanasios pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy
AT xanthostheodoros pharmacokineticdispositionofamiodaronewhengivenwithanintralipidrescuestrategy